Cell-based therapy in ovarian cancer: improved adenoviral transduction strategy of human mesenchymal stem cells as tumor-homing drug factories

Kuroki, Lindsay

148
Cell-based therapy in ovarian cancer: improved adenoviral transduction strategy of human mesenchymal stem cells as tumor-homing drug factories

Sunday, March 29, 2015: 3:05 PM

Salon C-D (Hilton Chicago)

L. M. Kuroki¹, I. Dmitriev¹, J. Gibbs¹, K. Tatzel¹, M. A. Powell¹, D. G. Mutch¹, A. B. Dietz², D. T. Curiel¹, W. Hawkins¹ and D. Spitzer¹
¹Washington University School of Medicine, St. Louis, MO, ²Mayo Clinic, Rochester, MN

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

148
Cell-based therapy in ovarian cancer: improved adenoviral transduction strategy of human mesenchymal stem cells as tumor-homing drug factories

148 Cell-based therapy in ovarian cancer: improved adenoviral transduction strategy of human mesenchymal stem cells as tumor-homing drug factories

148
Cell-based therapy in ovarian cancer: improved adenoviral transduction strategy of human mesenchymal stem cells as tumor-homing drug factories